Eric Hsu
Fortune : 3 $ au 31/08/2026
Fortune : 3 $ au 31/08/2026
Dr. Eric C.
Hsu is a Senior VP-Pre-Clinical Research & Development at InMed Pharmaceuticals, Inc. Dr. Hsu was previously employed as a VP-Scientific Affairs, Research & Operations by enGene, Inc. He received his undergraduate degree from McGill University and a doctorate degree from the University of Toronto.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/12/2025 | 2 ( 0 % ) | 3 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | 13/03/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Directeur des opérations | 01/01/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national